BioVoice News December 2017-January 2018 Issue 7 Volume 2 | Page 49

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: tech providers “ India is the second largest supplier of generic drugs by value, and the largest supplier by volume to the global marketplace.” Devashish Ohri one such PTM: protein glycosylation, which is the attachment of carbohydrates to a protein structure. It has been recognized that protein glycosylation can be a critical quality attribute for proteins used for discovery and biotherapeutics, as it often plays a key role in the efficacy, safety, stability and functionality of the protein. We are working to better understand and document the role of raw materials in the variability and control of this process. Additionally, we are working with biopharmaceutical researchers and manufacturers to better understand how trace elemental impurities can impact the glycosylation pattern. Quality and consistency of raw materials is critical for managing the quality BioVoiceNews.com 49